Anti-human CD94 Antibody

Product Details


Clone094AB
ApplicationFlow Cytometry
ReactivityHuman
FormatPurified
Target NameCD94, KP43
IsotypeRabbit IgG
Antibody TypeMonoclonal
Regulatory StatusRUO
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide
Protein Concentration0.5 mg/mL
Storage & HandlingThe antibody solution should be stored between 2°C and 8°C
Recommended UsageFor flow cytometric staining, it is recommended to use less than 0.2 µg of this reagent per 0.5-1.0 million cells in a 100 µL volume. Optimal reagent performance should be determined by titration for each specific application
See All FormatsClone 094AB

Background Information


CD94, encoded by the KLRD1 gene, is a C-type lectin-like receptor expressed primarily on natural killer (NK) cells and subsets of T cells, particularly NKT-like and CD8+ T cells. CD94 plays an important role in regulating cytotoxic lymphocyte activity by recognizing major histocompatibility complex class I (MHC-I)-related molecules and helping NK cells distinguish healthy cells from cells undergoing infection or transformation. Its function depends strongly on the receptor it associates with, allowing CD94-containing complexes to deliver either inhibitory or activating signals.



CD94 is a type II transmembrane glycoprotein belonging to the C-type lectin-like receptor family. It contains a short cytoplasmic region, a transmembrane domain, and an extracellular C-type lectin-like domain. CD94 commonly forms heterodimers with members of the NKG2 family, including NKG2A, NKG2B, NKG2C, and NKG2E. The principal ligands for CD94/NKG2 receptors are HLA-E molecules presenting specific peptides derived largely from the leader sequences of other HLA class I proteins. CD94/NKG2A generally mediates inhibitory signaling, whereas CD94/NKG2C is associated with activating responses through the adaptor protein DAP12.



The CD94/NKG2-HLA-E axis contributes to immune surveillance and is involved in the regulation of antiviral and antitumor immunity. Altered expression or signaling of CD94-containing receptors has been reported in cancer, viral infections, and autoimmune or inflammatory conditions. Tumors may exploit inhibitory CD94/NKG2A signaling to evade NK- and T-cell-mediated immune responses, while certain chronic viral infections can alter the balance of CD94 receptor expression and activity.



Because CD94-containing receptors regulate cytotoxic lymphocyte responses, they are being investigated as potential targets for immunotherapy. Blocking inhibitory NKG2A/CD94 signaling may enhance NK- and T-cell activity against tumors, particularly when combined with other immune checkpoint inhibitors. Conversely, activating pathways involving CD94/NKG2C may potentially enhance antitumor or antiviral immunity. CD94 is therefore a useful marker for studying NK-cell biology and an emerging target for therapeutic strategies aimed at modulating innate and adaptive immune responses.

Isotype Control


Rabbit IgG, κ2 Isotype Control Antibody

Data Sheets


Anti-human CD94 Antibody TDS

Related Protocols


Flow Cytometry Protocol


Have a product or application question? Consult our FAQs or contact us.